Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy.
Behbehani, Gregory K
Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy. [electronic resource] - Cancer discovery Sep 2015 - 988-1003 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
2159-8290
10.1158/2159-8290.CD-15-0298 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers
Bone Marrow Cells--metabolism
Bone Marrow Examination
Cell Cycle--genetics
Cluster Analysis
Flow Cytometry
Genotype
Humans
Immunophenotyping
Karyotype
Leukemia, Myeloid, Acute--diagnosis
Neoplastic Stem Cells--metabolism
Phenotype
Reproducibility of Results
Treatment Outcome
Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy. [electronic resource] - Cancer discovery Sep 2015 - 988-1003 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
2159-8290
10.1158/2159-8290.CD-15-0298 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers
Bone Marrow Cells--metabolism
Bone Marrow Examination
Cell Cycle--genetics
Cluster Analysis
Flow Cytometry
Genotype
Humans
Immunophenotyping
Karyotype
Leukemia, Myeloid, Acute--diagnosis
Neoplastic Stem Cells--metabolism
Phenotype
Reproducibility of Results
Treatment Outcome